Indo-Bangla Pharmaceuticals (DHA:IBP) Shares Buyback Ratio %: 0.00 (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:IBP Indo-Bangla Pharmaceuticals Ltd DHA:IBP
32 GF Score
Price BDT16.70
View Full Analysis

What is Indo-Bangla Pharmaceuticals Shares Buyback Ratio %?

Indo-Bangla Pharmaceuticals DHA:IBP -2.34% 32 Shares Buyback Ratio % is 0.00 as of Aug. 25, 2026. GuruFocus rates DHA:IBP with a GF Score™ of 32/100.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Indo-Bangla Pharmaceuticals's current shares buyback ratio was 0.00%.

Indo-Bangla Pharmaceuticals Shares Buyback Ratio % Related Terms

Indo-Bangla Pharmaceuticals Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for Indo-Bangla Pharmaceuticals's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo-Bangla Pharmaceuticals Shares Buyback Ratio % Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
Shares Buyback Ratio %

Indo-Bangla Pharmaceuticals Semi-Annual Data
Shares Buyback Ratio %
DHA:IBP
32GF Score
Indo-Bangla Pharmaceuticals Ltd DHA:IBP
Shares Buyback Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo-Bangla Pharmaceuticals Shares Buyback Ratio % Calculation

Indo-Bangla Pharmaceuticals's Shares Buyback Ratio for the fiscal year that ended in . 20 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: . 20 ) - Shares Outstanding (EOP) (A: . 20 )) / Shares Outstanding (EOP) (A: . 20 )
=( - ) /
=N/A%

Indo-Bangla Pharmaceuticals's Shares Buyback Ratio for the quarter that ended in . 20 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: . 20 ) - Shares Outstanding (EOP) (A: . 20 )) / Shares Outstanding (EOP) (A: . 20 )
=( - ) /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of 0.00 mean?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a Shares Buyback Ratio % of 0.00 as of Aug. 25, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Indo-Bangla Pharmaceuticals and its competitors.
Is Indo-Bangla Pharmaceuticals' Shares Buyback Ratio % too high?
Indo-Bangla Pharmaceuticals' current Shares Buyback Ratio % is 0.00. Overall, Indo-Bangla Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Indo-Bangla Pharmaceuticals' Shares Buyback Ratio % compare to ?
Indo-Bangla Pharmaceuticals' Shares Buyback Ratio % of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Drug Manufacturers company?
A good Shares Buyback Ratio % depends on the Drug Manufacturers industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Indo-Bangla Pharmaceuticals and its competitors. Indo-Bangla Pharmaceuticals's current Shares Buyback Ratio % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo-Bangla Pharmaceuticals stock overvalued right now?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a current Shares Buyback Ratio % of 0.00. The current Shares Buyback Ratio % is 0.00. Indo-Bangla Pharmaceuticals' overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For Indo-Bangla Pharmaceuticals (DHA:IBP), the current Shares Buyback Ratio % is 0.00 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indo-Bangla Pharmaceuticals Business Description

Comparable Companies
Address Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.
32GF Score

Get the complete analysis for DHA:IBP

Shares Buyback Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT16.70
Price